What are the causes and treatments of hematospermia (blood in semen)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hematospermia: Causes and Management

Direct Recommendation

For men under 40 years with a single episode of hematospermia and no associated symptoms, reassurance and watchful waiting is appropriate without imaging, as this represents a benign self-limited condition in the vast majority of cases. 1, 2


Age-Based Algorithmic Approach

Men <40 Years Old with Transient/Single Episode

  • No imaging is required if the patient has no associated symptoms (fever, weight loss, bone pain, lower urinary tract symptoms) and no risk factors (cancer history, bleeding disorders, urogenital malformations). 1, 2, 3

  • Initial workup should include:

    • Visual confirmation that blood originates from ejaculate (not partner's postcoital bleeding) 1, 2
    • Urinalysis and urine culture 1
    • Testing for sexually transmitted infections if sexually active 3
    • Complete blood count and coagulation studies 1, 2
    • Semen analysis 1, 2
  • When infection is the most common cause in this age group (approximately 40% of cases), treatment should target identified pathogens. 1, 4, 5

Men ≥40 Years OR Any Age with Persistent/Recurrent Hematospermia

  • All men ≥40 years require prostate-specific antigen (PSA) screening to evaluate for prostate cancer. 1, 2

  • Transrectal ultrasound (TRUS) should be the first-line imaging modality, demonstrating abnormalities in 82-95% of men with hematospermia. 1, 2

    • TRUS identifies: prostatic calcifications/calculi, ejaculatory duct or seminal vesicle cysts, benign prostatic hyperplasia, prostatitis, and Cowper gland masses 1, 2
    • Important caveat: Some TRUS findings (prostatic calcifications, benign prostatic hyperplasia, nonobstructing cysts) are age-related changes found in asymptomatic patients and may not be causative. 1
  • MRI pelvis (with or without contrast) is indicated when TRUS is negative or inconclusive. 1, 2

    • MRI provides superior soft tissue contrast, multiplanar imaging, and operator-independent evaluation 1, 2
    • MRI better characterizes ejaculatory duct obstruction, determines origin of midline/paramedian prostatic cysts, and identifies location and age of hemorrhage within the seminal tract 1
    • Seminal vesicle width >1.7 cm suggests pathology 1

Common Etiologies by Clinical Context

Iatrogenic (Most Common in Men ≥40)

  • Prostate biopsy is the leading cause in older men, typically self-resolving. 3, 5

Infectious/Inflammatory (Most Common in Men <40)

  • Prostatitis, seminal vesiculitis, urethritis, or sexually transmitted infections account for ~40% of all cases. 1, 4, 5

Structural Abnormalities

  • Ejaculatory duct obstruction, prostatic/seminal vesicle cysts, calculi, or ductal obstruction 1, 4

Systemic Causes

  • Uncontrolled hypertension, coagulopathy, anticoagulant use, or hematologic disorders require blood pressure measurement and coagulation assessment. 1, 5

Red Flags Requiring Immediate Further Investigation

  • Associated symptoms: Fever, chills, weight loss, bone pain, lower urinary tract symptoms 3, 5
  • Persistent or recurrent episodes despite initial management 1, 2
  • Age ≥40 years (higher malignancy risk) 1, 3
  • Abnormal PSA or prostate examination 1, 3

Advanced Diagnostic Modalities

  • Transurethral seminal vesiculoscopy has 74.5% diagnostic accuracy (versus 45.3% for TRUS alone) and is most useful for detecting calculi and ejaculatory duct obstruction/stricture. 1, 2

  • TRUS-guided aspiration of seminal vesicles can confirm ejaculatory duct obstruction or provide definitive diagnosis of cystic lesions. 1

  • CT pelvis and arteriography are NOT appropriate (rated 1-2 on ACR appropriateness scale) and expose patients to unnecessary radiation. 1


Treatment Strategy

  • Treatment is directed at the underlying cause once identified: 2

    • Antibiotics for documented infection 3, 4
    • Correction of coagulopathy if present 2
    • Urologic referral for persistent cases requiring vesiculoscopy or surgical intervention 1, 2
  • Reassurance remains appropriate even when imaging reveals no definitive cause, as many cases remain idiopathic despite modern imaging. 1, 2


Critical Pitfalls to Avoid

  • Do not routinely image young men (<40) with single episodes – this leads to unnecessary anxiety, cost, and potential overdiagnosis of incidental findings. 1, 2

  • Do not skip PSA testing in men ≥40 – prostate cancer must be excluded in this population. 1, 2

  • Do not assume TRUS findings are causative – age-related changes like prostatic calcifications are common in asymptomatic men. 1

  • Do not use MRI to screen for prostate cancer – MRI's role is anatomic evaluation of the seminal tract, not cancer screening. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Hematospermia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation and treatment of hematospermia.

American family physician, 2009

Research

Etiologic classification, evaluation, and management of hematospermia.

Translational andrology and urology, 2017

Research

Hematospermia-a Symptom With Many Possible Causes.

Deutsches Arzteblatt international, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.